Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Publishing timestamp: 2024-02-20 14:15:29
Summary
The launch of the Alzheimer's drug Leqembi by Biogen and Eisai is off to a slow start, but demand is rising. Apple's new mixed reality headset, Vision Pro, has received mixed reviews with some users experiencing discomfort like headaches and motion sickness. Experts suggest taking breaks and moderating usage to alleviate symptoms.
Sentiment: MIXED
Tickers: BIIB, 4523.T-JP, ESALY,
Keywords: health care industry, biogen inc, eisai co ltd, science, biotech and pharmaceuticals, business news,